Atopic Dermatitis Connect
  • Saved

1mo

post on mc

  • Saved

1mo

In moderate-to-severe atopic dermatitis, what best reflects disease control in your practice?

  • Saved

1mo
The cutaneous microbiome: microbial remodeling of the skin lipid landscape. - PubMed

The cutaneous microbiome: microbial remodeling of the skin lipid landscape. - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/42267822

Discover how underexplored microbial lipid transformations affect skin health and offer therapeutic potential for acne and atopic dermatitis.


Recent findings highlight the underexplored role of microbial lipids in shaping the cutaneous lipid landscape, impacting conditions like acne and atopic dermatitis.

  • 1mo
    This is a topic that is receiving more attention lately and clearly plays a role in multiple dermatological disorders like AD, PsO, acne, and rosacea. Therapies that focus on this Show More
  • Saved

1yr
Breakthroughs in Dermatologic Care at the 2025 AAD Annual Meeting

The 2025 AAD Annual Meeting showcased key advancements in dermatologic care, including AI-driven innovations, novel therapies, and holistic patient management. Dr. Kathryn Schwarzenberger, MD, Professor of Dermatology at Oregon Health & Science University (OHSU) School of Medicine, and Dr. Linda Stein Gold, MD, FAAD, Director of Dermatology Clinical Research at Henry Ford Health System, led discussions on emerging treatment strategies. Dr. Stein Gold presented data from the ADORING 3 trial on tapinarof cream 1%, highlighting its steroid-free, long-term efficacy in atopic dermatitis, including pediatric patients.

Additional discussions covered lebrikizumab’s sustained benefits in moderate-to-severe atopic dermatitis and emerging evidence on IL-17/IL-23 inhibitors improving mental health in psoriasis. The conference emphasized technology’s role in transforming dermatology practice and the importance of interdisciplinary collaboration in patient care.

  • Saved

3yr

Discussion: This retrospective cohort study of patients enrolled in the KPNC healthcare system addresses an important gap in the scientific literature by describing IRs of malignancies in patients with moderate and severe AD.

Rates of malignancies among patients with moderate to severe atopic dermatitis: a retrospective cohort study - PubMed

Rates of malignancies among patients with moderate to severe atopic dermatitis: a retrospective cohort study - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/36898743/

The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site. The site is secure....

  • 3yr
    While this subject clearly deserves further investigation, it is not surprising to learn about an increased incidence of malignancies such as NMSC and breast cancer in moderate to severe AD Show More